Novavax

novavax.com

Novavax is a global biotechnology company focused on the discovery, development, and delivery of innovative vaccines to combat serious infectious diseases. Utilizing proprietary recombinant protein-based nanoparticle technology and the Matrix-M™ adjuvant, Novavax aims to enhance immune responses and provide effective vaccination solutions. The company is actively engaged in clinical trials and research to address current and emerging public health threats, positioning itself as a leader in the vaccine development space with a commitment to safety and efficacy in its trials.